TABLE 2.
Serotype | Toxinb | CDS absent (%) |
---|---|---|
O26:K60 | VT | 7.2 (0.9) |
O26:K60 | None | 7.3 (0.6) |
O86:K61 | CLDT | 19.5 (0.7) |
O157:H7 | VT | 9.8 (0.2) |
O55:K+ | None | 5.9 (0.8) |
Untypeable | VT | 11 |
O111:K+ | None | 10 |
O126:K+ | None | 7.4 |
O29:K+ | None | 5.1 |
K-12 ΔgalK-bioD | N/A | 2.6 |
K-12 Δgpt-lac | N/A | 3.2 |
K-12 | N/A | 0 |
The percentage of CDS absent in the test strains, with respect to the control MG1655 strain, was assessed by microarray analyses. The average value of the percentage of CDS missing for each serogroup (where n > 1) was calculated, and the standard deviation is given in parentheses.
CLDT, cytolethal distending toxin; N/A, not applicable.